
    
      The objective of the study is to evaluate subjects with XLRS in a clinical setting and gather
      data on disease progression. The data from this study will enhance the understanding of the
      natural history of this rare disease and will facilitate appropriately powered safety studies
      in a future gene therapy trial in humans.
    
  